Cancer Immunotherapy: Promise and Pitfalls

Cancer Immunotherapy: Promise and Pitfalls

Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.


Published

May 23, 2018

Created by

UCSF MedConnection

Related Presenters

Hope Rugo, MD

Hope Rugo, MD

Dr. Hope Rugo is a hematologist and oncologist specializing in breast cancer treatment.

View profile

David Oh, MD

David Oh, MD

Dr. David Oh is a clinical fellow in hematology/oncology at UCSF. He received an M.D. as well as a PhD in physiology from Stanford University and did a residency in internal medicine at UCSF before beginning his fellowship.

View profile